Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
GLAND
GLAND
2,959.30-15.0 (-0.50%)
8 Sep, 12:00 AM

Stock Scores

Quality Score

91.9 / 100

Value Score

28.0 / 100

Price Momentum Score

95.2 / 100

QVM Score

91.5 / 100

Key Metrics

Market Cap
48818.70
P/E (TTM)
43.25
P/B
4.71
P/S (TTM)
7.26
EV/EBITDA
26.08
CAPE (5Y)
54.72
ROE (TTM)
10.53
ROCE (TTM)
12.00
ROA (TTM)
8.66
Avg 3Y ROE
9.20
Earnings 3Y CAGR
14.73
Sales 3Y CAGR
19.14
Sales 5Y CAGR
12.50
Debt/Equity
0.03
Consensus TP
2985.00
Strong Buy %
40.00
Promoter Holding
51.77
Pledged %
0.00

Share Price

Track Gland Pharma Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

1 Week returns: 2.93 %
Low
2,803.0
High
3,042.0
1 Month returns: 13.78 %
Low
2,610.1
High
3,042.0
1 Year returns: 57.97 %
Low
1,573.6
High
3,042.0
3 Year CAGR: 20.29 %
Low
1,200.0
High
3,042.0
5 Year CAGR: -5.56 %
Low
861.0
High
4,179.6
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Financial Snapshot

See detailed analysis

Multi-year trends for Gland Pharma Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Gland Pharma Ltd. Shareholding Pattern

Quarterly breakdown of Gland Pharma Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Gland Pharma Ltd. shares as reported to NSE and BSE.

Frequently Asked Questions

What is the current share price of Gland Pharma Ltd.?
The current share price of Gland Pharma Ltd. is ₹ 2,959.30 as of 8 Sep 2026.
What is the market capitalisation of Gland Pharma Ltd.?
The market capitalisation of Gland Pharma Ltd. stands at ₹ 48,818.70 Cr.
What is the PE ratio of Gland Pharma Ltd.?
The Price-to-Earnings (PE) ratio of Gland Pharma Ltd. is 43.25 as of the latest trailing twelve months data.
What is the ROE and ROCE of Gland Pharma Ltd.?
Gland Pharma Ltd. has a Return on Equity (ROE) of 10.53% and a Return on Capital Employed (ROCE) of 12.00% as per the latest financial reports.
What is the 52-week high and low of Gland Pharma Ltd.?
The 52-week high of Gland Pharma Ltd. is - and the 52-week low is -.
What is the dividend yield of Gland Pharma Ltd.?
The dividend yield of Gland Pharma Ltd. is 0.68% based on the current market price.
What is the FII and DII holding in Gland Pharma Ltd.?
Foreign Institutional Investors (FII) hold 8.74%, Domestic Institutional Investors (DII) hold 29.51% and retail/public investors hold 4.03% of Gland Pharma Ltd. shares.
What sector does Gland Pharma Ltd. belong to?
Gland Pharma Ltd. operates in the Healthcare sector. 73.33% of analysts have a Buy or Strong Buy rating on Gland Pharma Ltd. with a consensus target price of ₹ 2,985.00, implying 0.87% upside from current levels.
What is the beta of Gland Pharma Ltd.?
The beta of Gland Pharma Ltd. is 0.56, indicating its price volatility relative to the broader market. Over the past 1 year, Gland Pharma Ltd. has delivered an absolute return of 58.61%.
What is the RSI of Gland Pharma Ltd.?
The 14-day Relative Strength Index (RSI) of Gland Pharma Ltd. is 67.86, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.